Calidi Biotherapeutics, Inc. (CLDI) ownership: Top institutional holder: Finepoint Capital LP ($249000.00). Insider activity: Net Seller (4 buys, 16 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Finepoint Capital LP | 1042.00 | $249000.00 | 2026-03-31 |
| ARMISTICE CAPITAL, LLC | 879000.00 | $209905.00 | 2026-03-31 |
| SABBY MANAGEMENT, LLC | 434903.00 | $103855.00 | 2026-03-31 |
| Warberg Asset Management LLC | 250000.00 | $59475.00 | 2026-03-31 |
| VANGUARD GROUP INC | 34728.00 | $40632.00 | 2025-12-31 |
| HighTower Advisors, LLC | 83523.00 | $19945.00 | 2026-03-31 |
| Virtu Financial LLC | 75769.00 | $18000.00 | 2026-03-31 |
| CITADEL ADVISORS LLC | 71196.00 | $16375.00 | 2025-06-30 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 |
Back to CLDI overview · CLDI earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.